642-655 real questions | 642-655 practice questions | Luna Velvet

Pass4sure 642-655 dumps | 642-655 true questions |

642-655 WAASFE-Wide region Application Services for domain Engineers

Study pilot Prepared by Cisco Dumps Experts 642-655 Dumps and true Questions

100% true Questions - Exam Pass Guarantee with tall Marks - Just Memorize the Answers

642-655 exam Dumps Source : WAASFE-Wide region Application Services for domain Engineers

Test Code : 642-655
Test cognomen : WAASFE-Wide region Application Services for domain Engineers
Vendor cognomen : Cisco
real questions : 71 true Questions

Cisco WAASFE-Wide region Application

Cisco Acquisition Of Duo protection Makes tang | true Questions and Pass4sure dumps

No influence discovered, are trying current keyword!The acquisition of Duo protection via Cisco (CSCO) matches into the Cisco transformation ... Authentication is always carried out, anyplace, for any utility. in the pre-cloud area, clients had been trusted insi...

Google, Cisco amp-up industry cloud integration | true Questions and Pass4sure dumps

The joint Google and Cisco Kubernetes platform for industry valued clientele should materialize before the conclude of the year, and issues are getting warm between the two organizations ahead of that incredibly anticipated unencumber.

Cisco and Google ultimate October teamed up to ameliorate a Kubernetes hybrid-cloud providing.  Kubernetes, initially designed through Google, is an open-source-based system for developing and orchestrating containerized functions.

The Cisco/Google amalgam – which is at present being demonstrated via early entry industry valued clientele, according to Google – will let IT managers and software developers exercise Cisco paraphernalia to control their on-premises environments and link it up with Google’s public IaaS cloud which offers orchestration, security and ties to a vast developer community.

actually the developer neighborhood is one region the organizations acquire targeted recently through saw a Cisco & Google Cloud challenge, which is providing prizes cost over $a hundred and sixty,000 to ameliorate what Cisco calls “game-changing” apps using Cisco’s Container Platform with Google Cloud features.  Cisco says the purpose is to collect its DevNet group and Google’s expertise partners to bring current hybrid-cloud applications for enterprise shoppers.

Cisco VP & CTO of DevNet Susie Wee wrote in a blog that in instruction for the problem, DevNet is offering workshops, workplace hours, and sandboxes the exercise of Cisco Container Platform with Google Cloud capabilities to aid shoppers and builders learn the course to connect cloud data from a private cloud to the Google Cloud Platform and even information from facet instruments to elope analytics and employ machine studying.

 “as an example, a manufacturing unit may additionally acquire information from sensors combined with spot analytics from a Meraki cloud. through inspecting the records from these sources in Google Cloud, that you would live able to construct predictive fashions to forestall outage or breakdown expenses, with the aid of predicting failures ahead of time,” Wee wrote.

Cisco says it'll start accepting submissions in September and should opt for the winners in November.

Cisco has been touting the augment and impact of its personal DevNet community noting t the simultaneous Cisco are vital adventure that the community based in 2014, now has 500,000 registered individuals.

"Our 500,000 powerful group is writing code that will too live leveraged and shared by using others. DevNet is making a network-innovation ecosystem that may live the hub of the next technology of purposes and the next era of company," Wee referred to on the time. 

Google and Cisco evanesce AI, laptop discovering

engaging hybrid cloud developers isn’t the only action occurring between Cisco and Google. 

The agencies acquire moved ahead on plenty of current areas the first round ersatz Intelligence and desktop getting to know. 

Cisco pointed out it would convey Google synthetic Intelligence (AI) to its Cisco client adventure solutions. in line with Cisco, Contact hub AI is an easy, secure, and resilient solution that lets organizations with restricted desktop-gaining scholarship of abilities to install AI in their contact facilities.  The AI instantly provides brokers with valuable documents to assist e book conversations and invariably learns with a purpose to deliver increasingly more central assistance over time, the enterprise observed.

other imminent mixtures will encompass:

  • The potential to agenda a Webex assembly within a Google Calendar with one click on. “With an add-on from G Suite within the coming months, you will descry the Webex meetings icon each time you agenda a meeting in Google Calendar. click it to set up your video-first Webex assembly for the americans and rooms you need, and let the technology carry out the rest. "americans combine from a Cisco video machine by without vicissitude pushing the substantial green "be a share of" button. Or from a Chrome browser with just one click – no downloads or visitor debts required,” Cisco talked about.
  • The capability to add Cisco calling and meetings into an Android app. the exercise of Webex teams Android SDK, builders can add Cisco collaboration capabilities into their Android apps.  for example, consumers could add Cisco video meetings into smart glasses for a “see what I see” journey between, say, an expert on land and an engineer on a ship in the hub of the ocean, Cisco mentioned.
  • capacity to form exercise of Google medical doctors, Sheets, Slides and varieties in Webex groups areas. As americans collaborate on content more and more, Cisco and Google are exploring ways to form the job more straightforward.  No more limitless reposting of documents as people layer on current rounds of edits. submit it as soon as, edit it as time and again as you want, or co-collaborate on content material greater straight away.
  • Cisco moves on Kubernetes

    In other moves, Cisco in might too took large steps towards assisting clients installation, monitor and manipulate on-premises and public-cloud production-in a position Kubernetes-primarily based container functions. 

    Cisco rolled out  AppDynamics for Kubernetes and pointed out it will possibly sever back the time it takes to establish and troubleshoot efficiency issues across Kubernetes clusters in multicloud environments by using intelligently filtering performance metrics in line with Kubernetes labels. This Kubernetes-label filtering skill IT operations teams not should video parade lots of threads executing an analogous provider, Cisco referred to.

    at that time Cisco too pointed out its Cisco CloudCenter 4.9 will become a key point of the open, hybrid-cloud providing being developed by course of Cisco and Google and that is anticipated later this 12 months. 

    in line with Cisco with the free up of CloudCenter 4.9, users can, amongst different issues, exercise interface and utility-lifecycle administration facets to installation and manipulate containerized purposes in Kubernetes clusters; and set up clusters in a private statistics middle, which will too live created by course of the current Cisco Container Platform. The Cisco Container Platform may live an essential component of the Cisco and Google Cloud provider.

    introduced in January and too according to Kubernetes, Cisco Container Platform allows for for self-carrier deployment and management of container clusters.  the first version the container platform will function with Cisco’s HyperFlex ambiance with others to observe.

    join the community World communities on facebook and LinkedIn to observation on matter matters that are exact of mind.

    Multifactor Acquisition: Cisco Plans to buy Duo for $2.35B | true Questions and Pass4sure dumps

    Cisco intends to form exercise of Duo's authentication technology to ramp up security throughout hybrid and multicloud environments.

    Networking significant Cisco techniques has agreed to purchase authentication startup Duo protection for $2.35 billion in money and assumed fairness, the businesses validated nowadays.

    Duo, based in 2010 by course of Dug music and Jonathan Oberheide, specializes in cloud-based mostly multifactor authentication. purchasers of the Ann Arbor, Mich.-based enterprise range from SMBs to primary groups, the usage of its tech to determine users' identities through setting up believe of their identities, evaluating gadget trustworthiness, and facilitating restful application access.

    Now Cisco desires to present its customers the equal because it plans for a future in the cloud.

    "Cisco and Duo are aligned in the fashion of designing infrastructure for the extended enterprise," said David Goeckeler, government vice chairman and customary manager of Cisco's networking and security business, in a press briefing on the information. "clients, instruments, and functions are at the hub of simultaneous security structure."

    The acquisition became driven by using three core motives, he defined. For starters, it is going to let Cisco prolong intent-based mostly networking into multicloud environments. The industry at the flash gives on-premises network entry manage through its identification services Engine (ISE); it plans to present cloud-based entry manage by using integrating Duo's SaaS mannequin into its ISE product.

    Cisco's focal point is networking and commercial enterprise security, Goeckeler stated. Its intent is to securely connect consumers on various networks to any software at a time when more apps can live found outside the company and valued clientele are adopting multi- and hybrid-cloud environments.

    "the region has landed on multicloud," Duo's song said at the briefing. "We descry a extremely limpid role for us sitting on the intersection of that current community it's being constructed."

    Goeckler's 2d point became how the Duo acquisition will support simplify coverage for cloud protection by means of integrating trusted identification consciousness into Cisco's cozy cyber web Gateway, Cloud entry protection broker, commercial enterprise Mobility management, and different cloud-based mostly products in its lineup. His third point: Cisco will leverage Duo's gadget visibility to expand endpoint administration insurance.

    Cisco: Late to 2FA?Multifactor authentication is definitely a magnificent implement for Cisco to have, but it surely's a bit late for the company to acquire it, says Merritt Maxim, essential analyst serving safety and casual gurus at Forrester.

    "On one hand ... authentication is soundless one of the tolerable vulnerabilities that gets exploited for facts breaches," he explains. Compromised passwords proceed to live an issue, and two-component authentication is a considerable course to mitigate the chance.

    Cisco has historically invested in network or cloud-focused businesses; whereas Duo is "a bit a runt backyard the core area," Maxim says, it does complement Cisco's portfolio. Duo is on a excessive-trajectory augment cost, he continues, and has raised lots of capital.

    however, the tall cost tag suggests Cisco may well live "a runt late to the video game on this," Maxim provides, noting that the majority most well-known tech agencies acquire already invested in multifactor. If the industry desired two-factor authentication, it might acquire had it "a long time in the past." due to this fact, he anticipates the deal is about attaining consumers and boom moreover 2FA tech. Cisco desires to offer protection to the networks and users connecting to the cloud; Duo is a share of that.

    Maxim would not assume any main adjustments to Duo's multifactor know-how because of the acquisition. or not it's too intriguing, he points out, that Duo offers phishing simulation and consciousness equipment. Cisco may additionally doubtlessly leverage these in its content material strategy.

    As for Cisco's plans, "we descry Duo's casual with Cisco going past safety into its intent-based mostly networking approach," Goeckeler stated these days. whereas extra guidance on Duo's integration will live announced after the immediate of the deal, he celebrated plans to weave Duo's tech into Cisco items, in addition to to proceed to promote Duo's offerings as a standalone product.

    The acquisition is matter to closing conditions and is anticipated to shut in the first quarter of Cisco's 2019 fiscal yr. Following the shut, Duo's operations and 700-some employees may live integrated into Cisco's networking and safety division below Goeckeler's management. music will proceed to pilot Duo following the transaction, Cisco reports.

    related content:


    Black Hat united states returns to Las Vegas with fingers-on technical Trainings, cutting-side Briefings, Arsenal open-source device demonstrations, suitable-tier security solutions and repair suppliers within the enterprise corridor. click for counsel on the conference and to register.

    Kelly Sheridan is the staff Editor at darkish reading, where she specializes in cybersecurity information and analysis. She is a company expertise journalist who up to now said for InformationWeek, where she coated Microsoft, and coverage & know-how, where she coated fiscal ... View replete Bio

    more Insights

    642-655 WAASFE-Wide region Application Services for domain Engineers

    Study pilot Prepared by Cisco Dumps Experts 642-655 Dumps and true Questions

    100% true Questions - Exam Pass Guarantee with tall Marks - Just Memorize the Answers

    642-655 exam Dumps Source : WAASFE-Wide region Application Services for domain Engineers

    Test Code : 642-655
    Test cognomen : WAASFE-Wide region Application Services for domain Engineers
    Vendor cognomen : Cisco
    real questions : 71 true Questions

    While it is very arduous stint to select accountable certification questions / answers resources with respect to review, reputation and validity because people collect ripoff due to choosing wrong service. form it positive to serve its clients best to its resources with respect to exam dumps update and validity. Most of other's ripoff report complaint clients attain to us for the brain dumps and pass their exams happily and easily. They never compromise on their review, reputation and character because killexams review, killexams reputation and killexams client assurance is well-known to us. Specially they buy confidence of review, reputation, ripoff report complaint, trust, validity, report and scam. If you descry any fraudulent report posted by their competitors with the cognomen killexams ripoff report complaint internet, ripoff report, scam, complaint or something fondness this, just retain in intuition that there are always grim people damaging reputation of ample services due to their benefits. There are thousands of satisfied customers that pass their exams using brain dumps, killexams PDF questions, killexams practice questions, killexams exam simulator. Visit, their sample questions and sample brain dumps, their exam simulator and you will definitely know that is the best brain dumps site.

    Back to Braindumps Menu

    Killexams 1Z0-808 exam cram | Killexams 650-292 study guide | Killexams 000-M17 test prep | Killexams HP2-E14 mock exam | Killexams TT0-201 online test | Killexams HP2-K30 true questions | Killexams HT0-201 bootcamp | Killexams M9060-719 practice test | Killexams 117-301 study tools | Killexams 300-460 cheat sheet | Killexams GSSP-NET-CSHARP mock test | Killexams 156-708-70 practice exam | Killexams 642-978 flashcards | Killexams 9L0-625 bootcamp | Killexams HP0-663 practice Test | Killexams PEGACUIS71V1 test questions and answers | Killexams EX0-115 brain dumps | Killexams 640-878 essay questions | Killexams C2040-422 free pdf | Killexams 270-551 exam prep |

    642-655 test questions | 642-655 free pdf | 642-655 pdf download | 642-655 test questions | 642-655 real questions | 642-655 practice questions

    Exactly same 642-655 questions as in true test, WTF!
    Killexams.Com 642-655 Exam PDF consists of Complete Pool of Questions and Answers and Dumps checked and confirmed along with references and explanations (where relevant). Their target to congregate the Questions and Answers isnt always only to pass the exam at the genesis try but Really ameliorate Your scholarship about the 642-655 exam topics. Killexams.Com Huge Discount Coupons and Promo Codes are WC2017, PROF17, DEAL17, DECSPECIAL

    killexams.Com pinnacle rate 642-655 Exam Testing implement may live very facilitating for their clients for the exam instruction. replete vital functions, subjects and definitions are highlighted in intuition dumps pdf. Gathering the records in one region is a true time saver and enables you prepare for the IT certification examination inside a short time span. The 642-655 certification offers key points. The killexams.Com pass4sure dumps enables to memorize the captious functions or ideas of the 642-655 certification

    At killexams.Com, they provide thoroughly reviewed Cisco 642-655 schooling sources which can live the fine for clearing 642-655 check, and to collect licensed by using Cisco. It is a first-class preference to boost up your career as a professional within the Information Technology enterprise. They are pleased with their popularity of helping people immaculate the 642-655 test in their first actual tries. Their fulfillment rates within the beyond years were truly wonderful, thanks to their cheerful clients who're now capable of propel their careers inside the quick lane. Killexams.Com is the primary crave among IT professionals, specifically those who're looking to climb up the hierarchy tiers quicker of their respective agencies. Cisco is the industry leader in information technology, and getting licensed by means of them is a guaranteed course to live triumphant with IT careers. They assist you carry out precisely that with their tall exceptional Cisco 642-655 training materials. Cisco 642-655 is omnipresent replete over the world, and the commercial enterprise and software program solutions furnished by using them are being embraced by means of almost replete of the businesses. They acquire helped in driving heaps of agencies at the positive-shot course of success. Comprehensive expertise of Cisco products are taken into consideration a completely essential qualification, and the experts certified by means of them are rather valued in replete companies.

    We provide true 642-655 pdf exam questions and answers braindumps in two formats. Download PDF & practice Tests. Pass Cisco 642-655 book Exam speedy & without problems. The 642-655 syllabus PDF kind is to live had for studying and printing. You can print extra and practice often. Their bypass cost is tall to ninety eight.9% and the similarity percent among their 642-655 syllabus study pilot and actual examination is ninety% primarily based on their seven-year teaching enjoy. carry out you want achievements in the 642-655 examination in only one try? I am currently reading for the Cisco 642-655 syllabus examination.

    Cause replete that subjects here is passing the Cisco 642-655 examination. occasions replete which you want is a extreme rating of Cisco 642-655 examination. The best one component you want to carry out is downloading Examcollection 642-655 exam buy a sight at courses now. They will now not permit you to down with their cash-returned assure. The professionals additionally retain pace with the most updated exam for you to gift with the most people of up to date materials. One yr free collect admission to with a view to them through the date of purchase. Every applicants may afford the Cisco exam dumps thru killexams.Com at a low price. Often there is a reduction for replete people all.

    In the presence of the actual examination content of the brain dumps at killexams.Com you may without vicissitude broaden your region of interest. For the IT professionals, it's miles vital to enhance their competencies in line with their profession requirement. They form it immaculate for their clients to buy certification examination with the aid of killexams.Com validated and actual exam cloth. For a vibrant destiny within the world of IT, their intuition dumps are the pleasant alternative.

    A top dumps writing is a very essential feature that makes it smooth with a purpose to buy Cisco certifications. But Cisco braindumps PDF offers comfort for applicants. The IT certification is pretty a tough project if one does not find right guidance inside the form of just resource fabric. Thus, we've got genuine and up to date content for the guidance of certification exam.

    It is very well-known to collect to the factor material if one desires to shop time. As you want masses of time to sight for up to date and true examine cloth for taking the IT certification examination. If you find that at one location, what can live better than this? Its handiest killexams.Com that has what you want. You can retain time and live far from hassle in case you buy Adobe IT certification from their internet site.

    Killexams.Com Huge Discount Coupons and Promo Codes are as under;
    WC2017 : 60% Discount Coupon for replete tests on website
    PROF17 : 10% Discount Coupon for Orders extra than $sixty nine
    DEAL17 : 15% Discount Coupon for Orders extra than $99
    DECSPECIAL : 10% Special Discount Coupon for replete Orders

    You acquire to collect the most updated Cisco 642-655 Braindumps with the precise solutions, that are prepared with the aid of killexams.Com experts, allowing the candidates to grasp scholarship about their 642-655 certification direction within the maximum, you will not find 642-655 products of such exceptional anywhere within the market. Their Cisco 642-655 practice Dumps are given to applicants at performing 100% of their exam. Their Cisco 642-655 check dumps are modern inside the marketplace, providing you with a threat to set aside together to your 642-655 exam inside the right manner.

    642-655 Practice Test | 642-655 cbt | 642-655 exam cram | 642-655 study guide | 642-655 practice exam | 642-655 cram

    Killexams 1Z0-520 free test | Killexams NS0-141 braindumps | Killexams HP0-663 cheat sheets | Killexams HP2-H27 boot camp | Killexams HP2-Z05 free pdf | Killexams C7020-230 test questions and answers | Killexams 050-886 mock exam | Killexams HP2-H35 practice Test | Killexams CAT-380 test questions | Killexams 70-544-CSharp test prep | Killexams HPE2-E55 study guide | Killexams C9560-658 online test | Killexams HP0-J43 practice exam | Killexams HP0-D14 true questions | Killexams 351-001 brain dumps | Killexams C_TERP10_66 practice questions | Killexams 132-S-900.7 entrance exam | Killexams 310-620 study guide | Killexams 200-001 test questions | Killexams 650-393 free test online |

    Killing the examination become too easy! I dont assume so.
    Failure to fib in those that means that it turned into those very moments that they couldnt discover ways to neglect however now they replete understand that whether or not or no longer there was some occasions to the runt aspect that they couldnt no longer descry simply yet those stuff that they werent speculated to understand so now you should recognise that I cleared my 642-655 buy a sight at and it become higher than some thing and yes I did with and it wasnt the sort of grim component at replete to buy a sight at on line for a alternate and not sulk at home with my books.

    am i able to find state-of-the-art dumps Q & A of 642-655 exam?
    It clarified the subjects in a rearranged manner. inside the just exam, I scored a 81% with out lots hassle, finishing the 642-655 examination in 75 mins I additionally read a awesome deal of captivating books and it served to skip properly. My achievement in the examination was the dedication of the dumps. I ought to without an grim lot of a stretch conclude its decently organized gist internal 2 week time. lots obliged to you.

    revel in assured via making ready 642-655 dumps.
    Killexams! Huge manner to you. Remaining month whilst i was too much concerned approximately my 642-655 exam this website assist me plenty for scoring excessive. As each person is awake of that 642-655 certification is too much arduous however for me it changed into not too much difficult, as I had 642-655 material in my hand. After experiencing such accountable fabric I endorsed to replete the college students to incline in the course of the high-quality instructional offerings of this internet site on line for your guidance. My reform goals are with you considering your 642-655 certificate.

    Do you want dumps trendy 642-655 exam to skip the exam?
    There is not a ample deal 642-655 exam substances out there, so I went in promote and purchased those 642-655 questions and solutions. in reality, it received my coronary heart with the manner the statistics is prepared. And yeah, thats right: mostquestions I noticed on the exam acquire been exactly what turned into furnished by Im relieved to acquire exceeded 642-655 exam.

    I got Awesome Questions bank for my 642-655 exam.
    Killexams.Com is straightforward and sturdy and you could bypass the examination if you evanesce through their question bank. No words to express as i acquire exceeded the 642-655 examination in first attempt. A few different question banks too are availble in the marketplace, but I tang killexams.Com is considerable amongst them. Im very assured and am going to exercise it for my unique exams additionally. Thanks plenty ..Killexams.

    i found an super supply for 642-655 question pecuniary institution.
    I set aside together human beings for 642-655 exam problem and mention replete to your web site for similarly developed making ready. that is positively the fine website that offers sturdy exam fabric. this is the fine asset I understand of, as ive been going to severa locales if no longer all, and i acquire presumed that Dumps for 642-655 is truely up to the mark. a entire lot obliged and the exam simulator.

    Do you want true qustions and solutions brand current 642-655 exam to bypass the examination?
    I had taken the 642-655 arrangement from the killexams.Com as that turned into a median diploma for the readiness which had in the conclude given the exceptional degree of the planning to set off the ninety % scores in the 642-655 checktests. I without a doubt extremely joyful inside the device I were given issues the matters emptied the exciting technique and thru the helpof the equal; I had at lengthy terminal got the detail out and about. It had made my association a ton of much less tough and with the aid of the killexams.Com I acquire been organized to expand properly inside the existence.

    Do you want true test questions modern-day 642-655 examination to set aside together?
    sooner or later, on the dinner table, my father asked me right now if i was going to fail my upcoming 642-655 check and that i answered with a very company No way. He become inspired with my assurance however i used to live so fearful of disappointing him. Thank God for this because it helped me in keeping my phrase and clearing my 642-655 buy a sight at with pleasant consequences. Im grateful.

    No less steeply-priced source than those 642-655 true questions dumps available however.
    I additionally had an excellent revel in with this coaching set, which led me to passing the 642-655 examination with over ninety eight%. The questions are true and valid, and the trying out engine is a super/education tool, even if youre no longer making plans on taking the examination and simply want to augment your horizons and enlarge your know-how. Ive given mine to a friend, who additionally works in this spot however just obtained her CCNA. What I imply is its a notable mastering implement for every person. And in case you blueprint to buy the 642-655 exam, this is a stairway to fulfillment :)

    Do you need dumps of 642-655 exam to pass the exam?
    I surpassed both the 642-655 first attempt itself with 80% and 73% resp. Thanks plenty on your help. The question pecuniary institution genuinely helped. I am thankful to killexams.Com for assisting lots with so many papers with solutions to paintings on if not understood. They had been extremely beneficial. Thankyou.

    Exam Simulator : Pass4sure 642-655 Exam Simulator

    View Complete list of Braindumps

    Killexams NSE7 practice questions | Killexams C_TSCM42_66 test prep | Killexams BCP-220 study guide | Killexams HP0-D02 free test | Killexams LOT-405 practice exam | Killexams VCP-410 practice Test | Killexams 000-241 dump | Killexams ST0-132 exam prep | Killexams 000-731 free test online | Killexams HP2-K25 flashcards | Killexams C2050-219 brain dumps | Killexams 2B0-100 cram | Killexams 7120X mock exam | Killexams HP2-K32 test questions | Killexams P2010-022 practice test | Killexams 70-343 sample test | Killexams 70-496 cbt | Killexams HP0-J27 cheat sheet | Killexams 000-559 study guide | Killexams 210-025 exam prep |


    Pass 4 positive 642-655 dumps | 642-655 true questions |

    Gene silencing with the aid of microRNAs: contributions of translational repression and mRNA rot | true questions and Pass4sure dumps

  • 1.

    Bartel, P. D. MicroRNAs: goal cognizance and regulatory capabilities. cell 136, 215–233 (2009).

  • 2.

    Voinnet, O. beginning, biogenesis, and pastime of plant microRNA. cellphone 136, 669–687 (2009).

  • 3.

    Krol, J., Loedige, I. & Filipowicz, W. The frequent legislation of microRNA biogenesis, feature and decay. Nature Rev. Genet. 11, 597–610 (2010).

  • 4.

    Carthew, R. W. & Sontheimer, E. J. Origins and mechanisms of miRNAs and siRNAs. cell 136, 642–655 (2009).

  • 5.

    Wu, L. & Belasco, J. G. Let me weigh the methods: mechanisms of gene law by means of miRNAs and siRNAs. Mol. phone 29, 1–7 (2008).

  • 6.

    Eulalio, A., Huntzinger, E. & Izaurralde, E. attending to the foundation of miRNA-mediated gene silencing. phone 132, 9–14 (2008).

  • 7.

    Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of set aside up-transcriptional law via microRNAs: are the solutions in sight? Nature Rev. Genet. 9, 102–114 (2008).

  • eight.

    Selbach, M. et al. widespread alterations in protein synthesis brought on by microRNAs. Nature 455, 58–sixty three (2008).

  • 9.

    Baek, D. et al. The influence of microRNAs on protein output. Nature 455, 64–71 (2008).

  • 10.

    Hendrickson, D. G. et al. Concordant legislation of translation and mRNA abundance for tons of of targets of a human microRNA. PLoS Biol. 7, e1000238 (2009).

  • eleven.

    Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to lessen target mRNA degrees. Nature 466, 835–840 (2010). References eight–11 file the first studies aimed at picking the contribution of translational repression and mRNA degradation to the ordinary consequence of animal miRNAs on a genome-huge level.

  • 12.

    Derry, M. C., Yanagiya, A., Martineau, Y. & Sonenberg, N. rules of poly(A)-binding protein via PABP-interacting proteins. bloodless Spring Harb. Symp. Quant. Biol. 71, 537–543 (2006).

  • 13.

    Olsen, P. H. & Ambros, V. The lin-four regulatory RNA controls developmental timing in Caenorhabditis elegans by means of blocking LIN-14 protein synthesis after the initiation of translation. Dev. Biol. 216, 671–680 (1999).

  • 14.

    Seggerson, ok., Tang, L. & Moss, E. G. Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev. Biol. 243, 215–225 (2002). References 13 and 14 are traditional papers that picture the first investigations of the mechanisms of miRNA-mediated gene silencing in C. elegans.

  • 15.

    Maroney, P. A., Yu, Y., Fisher, J. & Nilsen, T. W. facts that microRNAs are associated with translating messenger RNAs in human cells. Nature Struct. Mol. Biol. 13, 1102–1107 (2006).

  • 16.

    Nottrott, S., Simard, M. J. & Richter, J. D. Human let-7a miRNA blocks protein construction on actively translating polyribosomes. Nature Struct. Mol. Biol. 13, 1108–1114 (2006).

  • 17.

    Petersen, C. P., Bordeleau, M. E., Pelletier, J. & Sharp, P. A. short RNAs repress translation after initiation in mammalian cells. Mol. cell 21, 533–542 (2006).

  • 18.

    Pillai, R. S. et al. Inhibition of translational initiation by means of Let-7 MicroRNA in human cells. Science 309, 1573–1576 (2005).

  • 19.

    Humphreys, D. T., Westman, B. J., Martin, D. I. & Preiss, T. MicroRNAs manage translation initiation by means of inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail characteristic. Proc. Natl Acad. Sci. u . s . 102, 16961–16966 (2005). References 18 and 19 acquire been the first to record that miRNAs inhibit translation initiation.

  • 20.

    Wang, B., Love, T. M., call, M. E., Doench, J. G. & Novina, C. D. Recapitulation of short RNA-directed translational gene silencing in vitro. Mol. mobile 22, 553–560 (2006).

  • 21.

    Thermann, R. & Hentze, M. W. Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation. Nature 447, 875–878 (2007).

  • 22.

    Iwasaki, S., Kawamata, T. & Tomari, Y. Drosophila argonaute1 and argonaute2 employ separate mechanisms for translational repression. Mol. cell 34, fifty eight–sixty seven (2009).

  • 23.

    Mathonnet, G. et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding tangled eIF4F. Science 17, 1764–1767 (2007).

  • 24.

    Wakiyama, M., Takimoto, ok., Ohara, O. & Yokoyama, S. Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cellphone-free device. Genes Dev. 21, 1857–1862 (2007). References 20–24 portray the first mobilephone-free extracts that recapitulate miRNA-mediated gene silencing in vitro.

  • 25.

    Zdanowicz, A. et al. Drosophila miR2 primarily aims the m7GpppN cap structure for translational repression. Mol. cell 35, 881–888 (2009).

  • 26.

    Ding, X. C. & Grosshans, H. Repression of C. elegans microRNA ambitions at the initiation stage of translation requires GW182 proteins. EMBO J. 28, 213–222 (2009).

  • 27.

    Lim, L. P. et al. Microarray evaluation indicates that some microRNAs downregulate huge numbers of goal mRNAs. Nature 433, 769–773 (2005).

  • 28.

    Krützfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685–689 (2005).

  • 29.

    Bagga, S. et al. legislation by using let-7 and lin-4 miRNAs outcomes in target mRNA degradation. mobile 122, 553–563 (2005).

  • 30.

    Wu, L. & Belasco, J. G. Micro-RNA regulation of the mammalian lin-28 gene throughout neuronal differentiation of embryonal carcinoma cells. Mol. telephone. Biol. 25, 9198–9208 (2005). References 27–30 symbolize the first reports displaying that animal miRNAs set off goal degradation.

  • 31.

    Rehwinkel, J., Behm-Ansmant, I., Gatfield, D. & Izaurralde, E. a crucial position for GW182 and the DCP1:DCP2 decapping advanced in miRNA-mediated gene silencing. RNA 11, 1640–1647 (2005). the primary anatomize to exhibit that decapping factors are concerned in miRNA-mediated legislation.

  • 32.

    Rehwinkel, J. et al. Genome-vast evaluation of mRNAs regulated with the aid of Drosha and Argonaute proteins in Drosophila melanogaster. Mol. cellphone. Biol. 26, 2965–2975 (2006).

  • 33.

    Schmitter, D. et al. effects of Dicer and Argonaute down-rules on mRNA ranges in human HEK293 cells. Nucleic Acids Res. 34, 4801–4815 (2006).

  • 34.

    Behm-Ansmant, I. et al. mRNA degradation through miRNAs and GW182 requires both CCR4:not deadenylase and DCP1:DCP2 decapping complexes. Genes Dev. 20, 1885–1898 (2006). First sight at showing that the CCR4–CAF1–now not tangled is involved in miRNA-mediated silencing in animal cells. in conjunction with references 35 and 36, this sight at showed for the primary time that miRNAs set off deadenylation.

  • 35.

    Giraldez, A. J. et al. Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science 312, seventy five–seventy nine (2006).

  • 36.

    Wu, L., Fan, J. & Belasco, J. G. MicroRNAs direct quick deadenylation of mRNA. Proc. Natl Acad. Sci. country 103, 4034–4039 (2006).

  • 37.

    Eulalio, A. et al. goal-certain requirements for enhancers of decapping in miRNA-mediated gene silencing. Genes Dev. 21, 2558–2570 (2007).

  • 38.

    Eulalio, A. et al. Deadenylation is a frequent consequence of miRNA regulation. RNA 15, 21–32 (2009).

  • 39.

    Mishima, Y. et al. Differential regulation of germline mRNAs in soma and germ cells by means of zebrafish miR-430. Curr. Biol. 16, 2135–2142 (2006).

  • 40.

    Stark, A., Brennecke, J., Bushati, N., Russell, R. B. & Cohen, S. M. Animal microRNAs treat robustness to gene expression and acquire a significant acquire an impact on on 3′UTR evolution. mobile 123, 1133–1146 (2005).

  • 41.

    Farh, ok. k. et al. The common influence of mammalian microRNAs on mRNA repression and evolution. Science 310, 1817–1821 (2005).

  • forty two.

    Yekta, S., Shih, I. H. & Bartel, D. P. MicroRNA-directed cleavage of HOXB8 mRNA. Science 304, 594–596 (2004).

  • 43.

    Piao, X., Zhang, X., Wu, L. & Belasco, J. G. CCR4-not deadenylates mRNA linked to RNA-induced silencing complexes in human cells. Mol. mobilephone. Biol. 30, 1486–1494 (2010).

  • forty four.

    Chu, C. Y. & Rana, T. M. Translation repression in human cells via microRNA-caused gene silencing requires RCK/p54. PLoS Biol. four, e210 (2006).

  • 45.

    Fabian, M. R. et al. Mammalian miRNA RISC recruits CAF1 and PABP to acquire an consequence on PABP-stylish deadenylation. Mol. mobilephone 35, 868–880 (2009). This study, together with reference 64, confirmed that GW182 proteins interact with PABPC, implicating PABPC in miRNA-mediated silencing for the first time.

  • 46.

    Beilharz, T. H. et al. microRNA-mediated messenger RNA deadenylation contributes to translational repression in mammalian cells. PLoS ONE 4, e6783 (2009).

  • forty seven.

    Eulalio, A., Huntzinger, E. & Izaurralde, E. GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay. Nature Struct. Mol. Biol. 15, 346–353 (2008).

  • forty eight.

    Meister, G. et al. Identification of novel argonaute-associated proteins. Curr. Biol. 15, 2149–2155 (2005).

  • 49.

    Liu, J. et al. a stint for the P-body component GW182 in microRNA characteristic. Nature phone Biol. 7, 1261–1266 (2005).

  • 50.

    Jakymiw, A. et al. Disruption of GW their bodies impairs mammalian RNA interference. Nature mobile Biol. 7, 1267–1274 (2005).

  • fifty one.

    Ding, L., Spencer, A., Morita, okay. & Han, M. The developmental timing regulator AIN-1 interacts with miRISCs and can target the argonaute protein ALG-1 to cytoplasmic P their bodies in C. elegans. Mol. cellphone 19, 437–447 (2005). References 48–51, along side reference 31, had been the first to parade a job for GW182 proteins in silencing.

  • 52.

    Ding, L. & Han, M. GW182 family unit proteins are well-known for microRNA-mediated gene silencing. traits cellphone Biol. 17, 411–416 (2007).

  • 53.

    Zhang, L. et al. Systematic identification of C. elegans miRISC proteins, miRNAs, and mRNA aims by using their interactions with GW182 proteins AIN-1 and AIN-2. Mol. mobilephone 28, 598–613 (2007).

  • fifty four.

    Eulalio, A., Tritschler, F. & Izaurralde, E. The GW182 protein family in animal cells: current insights into domains required for miRNA mediated gene silencing. RNA 15, 1433–1442 (2009).

  • 55.

    Tritschler, F., Huntzinger, E. & Izaurralde, E. function of GW182 proteins and PABPC1 in the miRNA pathway: a sense of déjà vu. Nature Rev. Mol. phone Biol. 11, 379–384 (2010).

  • 56.

    until, S. et al. A conserved motif in Argonaute-interacting proteins mediates useful interactions in the course of the Argonaute PIWI domain. Nature Struct. Mol. Biol. 14, 897–903 (2007).

  • 57.

    Takimoto, okay., Wakiyama, M. & Yokoyama, S. Mammalian GW182 carries multiple Argonaute binding websites and features in microRNA-mediated translational repression. RNA 15, 1078–1089 (2009).

  • 58.

    Lian, S. L. et al. The C-terminal half of human Ago2 binds to assorted GW-rich areas of GW182 and requires GW182 to mediate silencing. RNA 15, 804–813 (2009).

  • 59.

    Lazzaretti, D., Tournier, I. & Izaurralde, E. The C-terminal domains of human TNRC6A, B and C silence bound transcripts independently of the Argonaute proteins. RNA 15, 1059–1066 (2009).

  • 60.

    Eulalio, A., Helms, S., Fritzsch, C., Fauser, M. & Izaurralde, E. A C-terminal silencing domain in GW182 is basic for miRNA feature. RNA 15, 1067–1077 (2009).

  • 61.

    Zipprich, J. T., Bhattacharyya, S., Mathys, H. & Filipowicz, W. magnitude of the C-terminal region of the human GW182 protein TNRC6C for translational repression. RNA 15, 781–793 (2009).

  • sixty two.

    Chekulaeva, M., Filipowicz, W. & Parker, R. numerous unbiased domains of dGW182 feature in miRNA-mediated repression in Drosophila. RNA 15, 794–803 (2009).

  • 63.

    Li, S. et al. Identification of GW182 and its novel isoform TNGW1 as translational repressors in Ago2-mediated silencing. J. cellphone Sci. 121, 4134–4144 (2008).

  • sixty four.

    Zekri, L, Huntzinger, E., Heimstädt, S. & Izaurralde, E. The silencing domain of GW182 interacts with PABPC1 to advertise translational repression and degradation of miRNA aims and is required for goal unencumber. Mol. mobile. Biol. 29, 6220–6231 (2009). This examine, along side reference 45, confirmed that GW182 proteins engage with PABPC, implicating PABPC in miRNA-mediated gene silencing for the primary time.

  • 65.

    Walters, R. W., Bradrick, S. S. & Gromeier, M. Poly(A)-binding protein modulates mRNA susceptibility to cap-stylish miRNA-mediated repression. RNA 16, 239–250 (2010).

  • sixty six.

    Huntzinger, E., Braun, E. J., Heimstädt, S., Zekri, L. & Izaurralde, E. Two PABPC-binding websites in GW182 proteins promote miRNA-mediated gene silencing. EMBO J. 29, 4146–4160 (2010).

  • 67.

    Kozlov, G., Safaee, N., Rosenauer, A. & Gehring, okay. Structural basis of binding of P-physique linked protein GW182 and Ataxin-2 with the aid of the MLLE region of poly(A)-binding protein. J. Biol. Chem. 285, 13599–13606 (2010).

  • sixty eight.

    Jinek, M., Fabian, M. R., Coyle, S. M., Sonenberg, N. & Doudna, J. A. Structural insights into the human GW182–PABC interaction in microRNA-mediated deadenylation. Nature Struct. Mol. Biol. 17, 238–240 (2010).

  • sixty nine.

    Wu, E. et al. Pervasive and cooperative deadenylation of 3′UTRs by means of embryonic microRNA families. Mol. phone forty, 558–570 (2010).

  • 70.

    Llave, C., Xie, Z., Kasschau, ok. D. & Carrington, J. C. Cleavage of Scarecrow-like mRNA pursuits directed with the aid of a class of Arabidopsis miRNA. Science 297, 2053–2056 (2002).

  • seventy one.

    Rhoades, M. W. et al. Prediction of plant microRNA aims. telephone a hundred and ten, 513–520 (2002). References 70 and seventy one tested that plant miRNAs trigger goal cleavage.

  • 72.

    Tang, G., Reinhart, B. J., Bartel, D. P. & Zamore, P. D. A biochemical framework for RNA silencing in flora. Genes Dev. 17, forty nine–sixty three (2003).

  • seventy three.

    Souret, F. F., Kastenmayer, J. P. & eco-friendly, P. J. AtXRN4 degrades mRNA in Arabidopsis and its substrates consist of selected miRNA aims. Mol. phone 15, 173–183 (2004).

  • seventy four.

    German, M. A. et al. global identification of microRNA-target RNA pairs by parallel evaluation of RNA ends. Nature Biotech. 26, 941–946 (2008).

  • seventy five.

    Addo-Quaye, C., Eshoo, T. W., Bartel, D. P. & Axtell, M. J. Endogenous siRNA and miRNA objectives recognized by using sequencing of the Arabidopsis degradome. Curr. Biol. 18, 758–762 (2008).

  • 76.

    Schwab, R. et al. particular results of microRNAs on the plant transcriptome. Dev. telephone 8, 517–527 (2005).

  • seventy seven.

    Chen, X. A microRNA as a translational repressor of APETALA2 in Arabidopsis flower building. Science 303, 2022–2025 (2004).

  • 78.

    Aukerman, M. J. & Sakai, H. regulation of flowering time and floral organ identity through a microRNA and its APETALA2-like target genes. Plant phone 15, 2730–2741 (2003).

  • 79.

    Gandikota, M. et al. The miRNA156/157 awareness component in the 3′ UTR of the Arabidopsis SBP domain gene SPL3 prevents early flowering by course of translational inhibition in seedlings. Plant J. forty nine, 683–693 (2007).

  • eighty.

    Brodersen, P. et al. frequent translational inhibition by using plant miRNAs and siRNAs. Science 320, 1185–1190 (2008).

  • eighty one.

    Lanet, E. et al. Biochemical evidence for translational repression via Arabidopsis microRNAs. Plant phone 21, 1762–1768 (2009).

  • 82.

    Dugas, D. V. & Bartel, B. Sucrose induction of Arabidopsis miR398 represses two Cu/Zn superoxide dismutases. Plant Mol. Biol. 67, 403–417 (2008).

  • 83.

    Todesco, M., Rubio-Somoza, I., Paz-Ares, J. & Weigel, D. a collection of target mimics for comprehensive evaluation of microRNA characteristic in Arabidopsis thaliana. PLoS Genet. 6, e1001031 (2010).

  • 84.

    Jackson, R. J., Hellen, C. U. & Pestova, T. V. The mechanism of eukaryotic translation initiation and ideas of its rules. Nature Rev. Mol. phone Biol. 11, 113–127 (2010).

  • 85.

    Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. & Weissman, J. S. Genome-large analysis in vivo of translation with nucleotide conclusion the usage of ribosome profiling. Science 324, 218–223 (2009).

  • 86.

    Jinek, M. & Doudna, J. A. A three-dimensional view of the molecular paraphernalia of RNA interference. Nature 457, 405–412 (2009).

  • PERPETUAL FEDERAL discounts bank : OF URBANA, OHIO announces 2nd QUARTER working consequences | true questions and Pass4sure dumps

    FOR instant liberate

    Contact: Michael R. Melvin cellphone: (937) 653-1700

    PERPETUAL FEDERAL consequence downs pecuniary institution OF URBANA, OHIO announces second QUARTER working outcomes

    April 21, 2017, Perpetual Federal consequence downs bank of Urbana, Ohio [OTC Pink: "PFOH"] nowadays reported fiscal second quarter internet revenue of $1.three million, or primary and diluted income per share of $0.fifty one, for the quarter ended March 31, 2017, in comparison to internet earnings of $1.three million, or basic and diluted revenue per share of $0.fifty two for the quarter ended March 31, 2016. For the six months ended March 31, 2017, the reductions bank reported $2.5 million of internet earnings, or $1.03 per share of fundamental and diluted income, compared to $2.5 million of web salary, or $1.00 per share of fundamental and diluted salary for the six months ended March 31, 2016.

    total belongings expanded $5.9 million, or 1.5%, to $392.6 million at March 31, 2017, from

    $386.6 million at September 30, 2016. total shareholders' equity improved $1.5 million, or 2.2%, from $67.2 million at September 30, 2016, to $sixty eight.7 million at March 31, 2017, due to internet revenue less dividends paid. The savings bank's capital ratios continue to live in extra of these required to live considered neatly-capitalized below U.S. banking regulations.

    Perpetual Federal consequence downs pecuniary institution a hundred and twenty North leading highway

    P.O. container 71

    Urbana, OH 43078-1659

    selected CONSOLIDATED monetary tips

    (In thousands, except per share data)

    chosen monetary circumstance information:

    (unaudited) 03/31/17


    total property



    Loans receivable, web



    Allowance for loan losses



    pastime demeanor deposits in different

    monetary associations

    forty three,710





    Shareholders' equity



    selected Operations data:

    Three Months Ended

    Six Months Ended

    03/31/17 03/31/16

    03/31/17 03/31/sixteen

    (unaudited) (unaudited)

    (unaudited) (unaudited)

    complete pastime profits

    $ 4,008

    $ four,031

    $ 8,025

    $ 7,824

    complete pastime cost




    2,a hundred forty five

    web activity income





    Provision for personal loan losses





    internet hobby profits after

    provision for mortgage losses 2,790 2,897 5,598 5,594

    other non-pastime salary





    working prices






    before earnings taxes





    income tax price





    web income

    $ 1,251

    $ 1,277



    income per share/basic

    and Diluted $ 0.51 $ 0.fifty two $ 1.03 $ 1.00

    Perpetual Federal consequence downs pecuniary institution posted this content on 21 April 2017 and is fully accountable for the counsel contained herein.allotted by using Public, unedited and unaltered, on 21 April 2017 18:fifty eight:20 UTC.

    Drugging the undruggable RAS: Mission viable? | true questions and Pass4sure dumps

  • 1.

    Cox, A. D. & Der, C. J. RAS historical past: The saga continues. small GTPases 1, 2–27 (2010).

  • 2.

    Vogelstein, B. et al. cancer genome landscapes. Science 339, 1546–1558 (2013).

  • 3.

    Thompson, H. US countrywide cancer Institute's current RAS undertaking targets an customary foe. Nature Med. 19, 949–950 (2013).

  • 4.

    Berndt, N., Hamilton, A. D. & Sebti, S. M. targeting protein prenylation for cancer remedy. Nature Rev. melanoma eleven, 775–791 (2011).

  • 5.

    Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and generally metastatic pancreatic ductal adenocarcinoma in mice. cancer cell 7, 469–483 (2005).

  • 6.

    Ji, H. et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 448, 807–810 (2007).

  • 7.

    Haigis, k. M. et al. Differential consequences of oncogenic KRAS and NRAS on proliferation, differentiation and tumor progress in the colon. Nature Genet. forty, 600–608 (2008).

  • 8.

    Brummelkamp, T. R., Bernards, R. & Agami, R. sturdy suppression of tumorigenicity with the aid of virus-mediated RNA interference. melanoma mobile 2, 243–247 (2002).

  • 9.

    Lim, okay. H. & Counter, C. M. discount in the requirement of oncogenic RAS signaling to activation of PI3K/AKT pathway throughout tumor renovation. cancer cellphone eight, 381–392 (2005).

  • 10.

    Singh, A. et al. A gene expression signature linked to “KRAS addiction” displays regulators of EMT and tumor telephone survival. cancer phone 15, 489–500 (2009).

  • eleven.

    Chin, L. et al. elementary position for oncogenic RAS in tumour renovation. Nature 400, 468–472 (1999).

  • 12.

    Collins, M. A. et al. Metastatic pancreatic cancer is contingent on oncogenic KRAS in mice. PLoS ONE 7, e49707 (2012).

  • 13.

    Fisher, G. H. et al. Induction and apoptotic regression of lung adenocarcinomas through legislation of a KRAS transgene within the presence and absence of tumor suppressor genes. Genes Dev. 15, 3249–3262 (2001).

  • 14.

    Kwong, L. N. et al. Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma. Nature Med. 18, 1503–1510 (2012).

  • 15.

    Ying, H. et al. Oncogenic KRAS maintains pancreatic tumors via law of anabolic glucose metabolism. telephone 149, 656–670 (2012). This anatomize indicates, in an autochthonous mannequin, that oncogenic KRAS is required for pancreatic tumour preservation, partly through its function in reprogramming anabolic glucose metabolism.

  • sixteen.

    Bos, J. L., Rehmann, H. & Wittinghofer, A. GEFs and GAPs: essential facets within the manage of small G proteins. cell 129, 865–877 (2007).

  • 17.

    Stephen, A. G., Esposito, D., Bagni, R. k. & McCormick, F. Dragging RAS lower back in the ring. melanoma mobilephone 25, 272–281 (2014).

  • 18.

    Ahearn, I. M., Haigis, ok., Bar-Sagi, D. & Philips, M. R. Regulating the regulator: publish-translational amendment of RAS. Nature Rev. Mol. telephone Biol. 13, 39–fifty one (2012).

  • 19.

    Reiss, Y., Goldstein, J. L., Seabra, M. C., Casey, P. J. & Brown, M. S. Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides. telephone 62, eighty one–88 (1990).

  • 20.

    James, G. L., Goldstein, J. L. & Brown, M. S. Polylysine and CVIM sequences of KRASB impose specificity of prenylation and treat resistance to benzodiazepine peptidomimetic in vitro. J. Biol. Chem. 270, 6221–6226 (1995).

  • 21.

    Whyte, D. B. et al. ok- and N-RAS are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J. Biol. Chem. 272, 14459–14464 (1997).

  • 22.

    Rowell, C. A., Kowalczyk, J. J., Lewis, M. D. & Garcia, A. M. Direct demonstration of geranylgeranylation and farnesylation of Ki-RAS in vivo. J. Biol. Chem. 272, 14093–14097 (1997).

  • 23.

    Vigil, D., Cherfils, J., Rossman, k. L. & Der, C. J. RAS superfamily GEFs and GAPs: validated and tractable targets for melanoma remedy? Nature Rev. melanoma 10, 842–857 (2010).

  • 24.

    supply, B. J. et al. Novel allosteric sites on RAS for lead generation. PLoS ONE 6, e25711 (2011).

  • 25.

    Buhrman, G. et al. analysis of binding web site scorching spots on the floor of RAS GTPase. J. Mol. Biol. 413, 773–789 (2011).

  • 26.

    Wang, W., Fang, G. & Rudolph, J. RAS inhibition by the exercise of direct RAS binding — is there a course forward? Bioorg. Med. Chem. Lett. 22, 5766–5776 (2012).

  • 27.

    Taveras, A. G. et al. RAS oncoprotein inhibitors: the discovery of mighty, RAS nucleotide exchange inhibitors and the structural resolution of a drug-protein complex. Bioorg. Med. Chem. 5, 125–133 (1997).

  • 28.

    Peri, F. et al. Design, synthesis and biological assessment of sugar-derived RAS inhibitors. Chembiochem 6, 1839–1848 (2005).

  • 29.

    Herrmann, C. et al. Sulindac sulfide inhibits RAS signaling. Oncogene 17, 1769–1776 (1998).

  • 30.

    Waldmann, H. et al. Sulindac-derived RAS pathway inhibitors target the RAS–RAF interplay and downstream effectors in the RAS pathway. Angew. Chem. Int. Ed Engl. 43, 454–458 (2004).

  • 31.

    Karaguni, I. M. et al. the current sulindac by-product IND 12 reverses RAS-brought on phone transformation. cancer Res. sixty two, 1718–1723 (2002).

  • 32.

    Karaguni, I. M. et al. current indene-derivatives with anti-proliferative properties. Bioorg. Med. Chem. Lett. 12, 709–713 (2002).

  • 33.

    Gonzalez-Perez, V. et al. Genetic and useful characterization of putative RAS/RAF interaction inhibitors in C. elegans and mammalian cells. J. Mol. sign. 5, 2 (2010).

  • 34.

    Kato-Stankiewicz, J. et al. Inhibitors of RAS/RAF1 interplay identified by two-hybrid screening revert RAS-stylish transformation phenotypes in human melanoma cells. Proc. Natl Acad. Sci. united states of america ninety nine, 14398–14403 (2002).

  • 35.

    Rosnizeck, I. C. et al. Stabilizing a weak binding status for effectors within the human RAS protein by means of cyclen complexes. Angew. Chem. Int. Ed Engl. 49, 3830–3833 (2010).

  • 36.

    Patgiri, A., Yadav, okay. k., Arora, P. S. & Bar-Sagi, D. An orthosteric inhibitor of the RAS–SOS interplay. Nature Chem. Biol. 7, 585–587 (2011).

  • 37.

    Chang, Y. S. et al. Stapled α-helical peptide drug development: a efficacious dual inhibitor of MDM2 and MDMX for p53-elegant melanoma therapy. Proc. Natl Acad. Sci. usa 110, E3445–E3454 (2013).

  • 38.

    Maurer, T. et al. Small-molecule ligands bind to a positive pocket in Ras and inhibit SOS-mediated nucleotide exchange endeavor. Proc. Natl Acad. Sci. united states of america 109, 5299–5304 (2012).

  • 39.

    sun, Q. et al. Discovery of small molecules that bind to KRAS and inhibit SOS-mediated activation. Angew. Chem. Int. Ed Engl. fifty one, 6140–6143 (2012).

  • forty.

    Shima, F. et al. In silico discovery of small-molecule RAS inhibitors that screen antitumor pastime via blockading the RAS-effector interplay. Proc. Natl Acad. Sci. united states of america 110, 8182–8187 (2013).

  • 41.

    Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A. & Shokat, k. M. KRAS (G12C) inhibitors allosterically manage GTP affinity and effector interactions. Nature 503, 548–551 (2013). This study describes a novel approach to selectively target RAS-G12C via covalently attaching small molecules to the cysteine at residue 12.

  • forty two.

    Chen, k. X. et al. A novel sort of highly efficacious irreversible hepatitis C virus NS5B polymerase inhibitors. J. Med. Chem. 55, 2089–2101 (2012).

  • 43.

    Ward, R. A. et al. constitution- and reactivity-based progress of covalent inhibitors of the activating and gatekeeper mutant sorts of the epidermal boom component receptor (EGFR). J. Med. Chem. 56, 7025–7048 (2013).

  • 44.

    Lim, S. M. et al. Therapeutic concentrated on of oncogenic KRAS by a covalent catalytic web page inhibitor. Angew. Chem. Int. Ed Engl. 53, 199–204 (2014). This study describes an strategy to selectively target G12C mutant RAS through covalently attaching a nucleotide analogue.

  • 45.

    Burns, M. C. et al. approach for concentrated on RAS with small molecules that set off SOS-mediated nucleotide alternate. Proc. Natl Acad. Sci. united states of america 111, 3401–3406 (2014). during this paper, compounds were described that prompt SOS-mediated nucleotide change and paradoxically inhibit downstream RAS signalling.

  • 46.

    Chen, X., Makarewicz, J. M., Knauf, J. A., Johnson, L. k. & Fagin, J. A. Transformation by HrasG12V is normally associated with mutant allele copy advantageous properties and is reversed via farnesyl transferase inhibition. Oncogene (2013).

  • forty seven.

    Liu, M. et al. concentrated on the protein prenyltransferases efficaciously reduces tumor progress in mice with KRAS-induced lung melanoma. Proc. Natl Acad. Sci. united states of america 107, 6471–6476 (2010).

  • forty eight.

    Marom, M. et al. Selective inhibition of RAS-dependent cell augment by course of farnesylthiosalisylic acid. J. Biol. Chem. 270, 22263–22270 (1995).

  • 49.

    Gana-Weisz, M. et al. The RAS antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation. Biochem. Biophys. Res. Commun. 239, 900–904 (1997).

  • 50.

    Haklai, R. et al. Dislodgment and accelerated degradation of RAS. Biochemistry 37, 1306–1314 (1998).

  • fifty one.

    Makovski, V., Haklai, R. & Kloog, Y. Farnesylthiosalicylic acid (salirasib) inhibits RHEB in TSC2-null ELT3 cells: a workable medicine for lymphangioleiomyomatosis. Int. J. cancer 130, 1420–1429 (2012).

  • 52.

    McMahon, L. P., Yue, W., Santen, R. J. & Lawrence, J. C. Jr. Farnesylthiosalicylic acid inhibits mammalian target of rapamycin (mTOR) activity each in cells and in vitro by using promoting dissociation of the mTOR-Raptor complex. Mol. Endocrinol. 19, one hundred seventy five–183 (2005).

  • fifty three.

    Hanker, A. B. et al. Differential requirement of CAAX-mediated posttranslational processing for RHEB localization and signaling. Oncogene 29, 380–391 (2010).

  • 54.

    Weisz, B. et al. a current practical RAS antagonist inhibits human pancreatic tumor growth in nude mice. Oncogene 18, 2579–2588 (1999).

  • 55.

    Haklai, R., Elad-Sfadia, G., Egozi, Y. & Kloog, Y. Orally administered FTS (salirasib) inhibits human pancreatic tumor augment in nude mice. cancer Chemother. Pharmacol. 61, 89–ninety six (2008).

  • 56.

    Laheru, D. et al. built-in preclinical and clinical progress of S-trans, trans-farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic melanoma. form investments. current medication 30, 2391–2399 (2012).

  • fifty seven.

    Wahlstrom, A. M. et al. Rce1 deficiency speeds up the construction of KRAS-precipitated myeloproliferative disease. Blood 109, 763–768 (2007).

  • fifty eight.

    Wahlstrom, A. M. et al. Inactivating Icmt ameliorates KRAS-induced myeloproliferative disease. Blood 112, 1357–1365 (2008).

  • 59.

    court, H. et al. Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia by the exercise of Notch suppression. J. Clin. form investments. 123, 4681–4694 (2013).

  • 60.

    Majmudar, J. D. et al. Amide-modified prenylcysteine based mostly ICMT inhibitors: structure–exercise relationships, kinetic evaluation and cellular characterization. Bioorg. Med. Chem. 20, 283–295 (2012).

  • 61.

    Manandhar, S. P., Hildebrandt, E. R. & Schmidt, W. k. Small-molecule inhibitors of the RCE1P CAAX protease. J. Biomol. parade 12, 983–993 (2007).

  • sixty two.

    winter-Vann, A. M. et al. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor endeavor in melanoma cells. Proc. Natl Acad. Sci. united states of america 102, 4336–4341 (2005).

  • 63.

    Chiu, V. okay. et al. RAS signalling on the endoplasmic reticulum and the Golgi. Nature mobile Biol. 4, 343–350 (2002).

  • sixty four.

    Cuiffo, B. & Ren, R. Palmitoylation of oncogenic NRAS is elementary for leukemogenesis. Blood one hundred fifteen, 3598–3605 (2010).

  • sixty five.

    Swarthout, J. T. et al. DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H- and N-RAS. J. Biol. Chem. 280, 31141–31148 (2005).

  • sixty six.

    Goodwin, J. S. et al. Depalmitoylated RAS traffics to and from the Golgi complicated via a nonvesicular pathway. J. mobile Biol. one hundred seventy, 261–272 (2005).

  • sixty seven.

    Rocks, O. et al. The palmitoylation machinery is a spatially organizing paraphernalia for peripheral membrane proteins. mobile 141, 458–471 (2010).

  • sixty eight.

    Rocks, O. et al. An acylation cycle regulates localization and activity of palmitoylated RAS isoforms. Science 307, 1746–1752 (2005).

  • sixty nine.

    Dekker, F. J. et al. Small-molecule inhibition of APT1 impacts RAS localization and signaling. Nature Chem. Biol. 6, 449–456 (2010).

  • 70.

    Resh, M. D. targeting protein lipidation in ailment. tendencies Mol. Med. 18, 206–214 (2012).

  • 71.

    Bivona, T. G. et al. PKC regulates a farnesyl-electrostatic switch on KRAS that promotes its association with BCL-XL on mitochondria and induces apoptosis. Mol. mobilephone 21, 481–493 (2006). This anatomize identified a kinase-driven phosphorylation that regulates KRAS4B membrane affiliation, subcellular localization and oncogenic properties.

  • seventy two.

    Sung, P. J. et al. Phosphorylated KRAS limits mobile survival via blocking BCL-XL sensitization of inositol trisphosphate receptors. Proc. Natl Acad. Sci. us of a one hundred ten, 20593–20598 (2013).

  • seventy three.

    Kollar, P., Rajchard, J., Balounova, Z. & Pazourek, J. Marine herbal items: bryostatins in preclinical and clinical studies. Pharm. Biol. 52, 237–242 (2013).

  • 74.

    Barcelo, C. et al. Phosphorylation at Ser181 of oncogenic KRAS is required for tumor increase. cancer Res. seventy four, 1190–1199 (2013).

  • 75.

    Lim, k. H., Ancrile, B. B., Kashatus, D. F. & Counter, C. M. Tumour preservation is mediated by using eNOS. Nature 452, 646–649 (2008).

  • seventy six.

    Lampson, B. L. et al. concentrated on eNOS in pancreatic cancer. cancer Res. seventy two, 4472–4482 (2012).

  • 77.

    Zhang, H., Constantine, R., Frederick, J. M. & Baehr, W. The prenyl-binding protein PrBP/δ: a chaperone participating in intracellular trafficking. vision Res. 75, 19–25 (2012).

  • 78.

    Chandra, A. et al. The GDI-like solubilizing factor PDEδ sustains the spatial corporation and signalling of RAS family unit proteins. Nature cell Biol. 14, 148–158 (2012).

  • 79.

    Zimmermann, G. et al. small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling. Nature 497, 638–642 (2013). This anatomize identified a small molecule that may disrupt KRAS4B affiliation with a protein chaperone, altering KRAS4B membrane trafficking and cellular activity.

  • eighty.

    Philips, M. R. RAS hitchhikes on PDE6δ. Nature mobile Biol. 14, 128–129 (2012).

  • 81.

    Jura, N., Scotto-Lavino, E., Sobczyk, A. & Bar-Sagi, D. Differential change of RAS proteins by using ubiquitination. Mol. mobilephone 21, 679–687 (2006).

  • eighty two.

    Sasaki, A. T. et al. Ubiquitination of KRAS enhances activation and allows binding to opt for downstream effectors. Sci. badge four, ra13 (2011).

  • 83.

    Sumita, okay. et al. Degradation of activated KRAS orthologue by course of KRAS-certain lysine residues is required for cytokinesis. J. Biol. Chem. 289, 3950–3959 (2014).

  • 84.

    Yang, M. H. et al. HDAC6 and SIRT2 adjust the acetylation status and oncogenic activity of mutant KRAS. Mol. cancer Res. eleven, 1072–1077 (2013).

  • 85.

    Baines, A. T., Xu, D. & Der, C. J. Inhibition of RAS for cancer medicine: the quest continues. Future Med. Chem. three, 1787–1808 (2011).

  • 86.

    Blasco, R. B. et al. CRAF, however not BRAF, is primary for progress of KRAS oncogene-driven non-small mobilephone lung carcinoma. cancer cell 19, 652–663 (2011).

  • 87.

    Collisson, E. A. et al. A significant function for RAF→MEK→ERK signaling within the genesis of pancreatic ductal adenocarcinoma. cancer Discov. 2, 685–693 (2012).

  • 88.

    Roskoski, R. Jr. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol. Res. sixty six, 105–143 (2012).

  • 89.

    Lyons, J. F., Wilhelm, S., Hibner, B. & Bollag, G. Discovery of a novel RAF kinase inhibitor. Endocr. Relat. melanoma 8, 219–225 (2001).

  • 90.

    Wilhelm, S. M. et al. BAY 43–9006 exhibits huge spectrum oral antitumor recreation and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases worried in tumor progress and angiogenesis. melanoma Res. 64, 7099–7109 (2004).

  • ninety one.

    Lito, P., Rosen, N. & Solit, D. B. Tumor adaptation and resistance to RAF inhibitors. Nature Med. 19, 1401–1409 (2013).

  • ninety two.

    Hatzivassiliou, G. et al. RAF inhibitors prime wild-category RAF to set off the MAPK pathway and raise boom. Nature 464, 431–435 (2010).

  • 93.

    Heidorn, S. J. et al. Kinase-useless BRAF and oncogenic RAS cooperate to favor tumor progression via CRAF. cellphone a hundred and forty, 209–221 (2010).

  • ninety four.

    Poulikakos, P. I., Zhang, C., Bollag, G., Shokat, k. M. & Rosen, N. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature 464, 427–430 (2010). References 92–ninety four determined that BRAF inhibitors trigger RAS-activation-stylish RAF dimerization and ERK activation instead of inactivation.

  • ninety five.

    corridor-Jackson, C. A. et al. Paradoxical activation of RAF by course of a novel RAF inhibitor. Chem. Biol. 6, 559–568 (1999).

  • ninety six.

    Oberholzer, P. A. et al. RAS mutations are linked to the construction of cutaneous squamous mobile tumors in sufferers handled with RAF inhibitors. J. Clin. Oncol. 30, 316–321 (2012).

  • 97.

    Su, F. et al. RAS mutations in cutaneous squamous-telephone carcinomas in sufferers treated with BRAF inhibitors. N. Engl. J. Med. 366, 207–215 (2012).

  • 98.

    Freeman, A. okay., Ritt, D. A. & Morrison, D. okay. outcomes of RAF dimerization and its inhibition on typical and disorder-linked RAF signaling. Mol. cellphone forty nine, 751–758 (2013).

  • 99.

    Gilmartin, A. G. et al. GSK1120212 (JTP-74057) is an inhibitor of MEK recreation and activation with conducive pharmacokinetic properties for sustained in vivo pathway inhibition. Clin. cancer Res. 17, 989–one thousand (2011).

  • 100.

    Engelman, J. A. et al. constructive exercise of PI3K and MEK inhibitors to deal with mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nature Med. 14, 1351–1356 (2008).

  • one zero one.

    Hatzivassiliou, G. et al. Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-pushed cancers. Nature 501, 232–236 (2013).

  • 102.

    Ishii, N. et al. enhanced inhibition of ERK signaling with the aid of a novel allosteric MEK inhibitor, CH5126766, that suppresses feedback reactivation of RAF pastime. cancer Res. seventy three, 4050–4060 (2013).

  • 103.

    Duncan, J. S. et al. Dynamic reprogramming of the kinome according to centered MEK inhibition in triple-poor breast cancer. cellphone 149, 307–321 (2012). This examine applied a kinome-vast strategy to establish MEK-inhibitor-prompted compensatory pursuits that may then live targeted to retain away from de novo resistance mechanisms.

  • 104.

    Little, A. S. et al. Amplification of the riding oncogene, KRAS or BRAF, underpins bought resistance to MEK1/2 inhibitors in colorectal melanoma cells. Sci. sign. four, ra17 (2011).

  • a hundred and five.

    Bollag, G. et al. clinical efficacy of a RAF inhibitor wants extensive target blockade in BRAF-mutant melanoma. Nature 467, 596–599 (2010).

  • 106.

    Morris, E. J. et al. Discovery of a novel ERK inhibitor with recreation in models of obtained resistance to BRAF and MEK inhibitors. melanoma Discov. three, 742–750 (2013).

  • 107.

    Gupta, S. et al. Binding of RAS to phosphoinositide 3-kinase p110 α is required for RAS-driven tumorigenesis in mice. mobile 129, 957–968 (2007).

  • 108.

    Castellano, E. et al. Requirement for interaction of PI3-kinase p110α with RAS in lung tumor renovation. cancer mobilephone 24, 617–630 (2013).

  • 109.

    Ebi, H. et al. Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers. J. Clin. invest. 121, 4311–4321 (2011).

  • one hundred ten.

    Britten, C. D. PI3K and MEK inhibitor mixtures: inspecting the facts in chosen tumor varieties. cancer Chemother. Pharmacol. seventy one, 1395–1409 (2013).

  • 111.

    Bodemann, B. O. & White, M. A. RAL GTPases and cancer: linchpin support of the tumorigenic platform. Nature Rev. cancer 8, 133–one hundred forty (2008).

  • 112.

    Neel, N. F. et al. The RALGEF–RAL effector signaling community: the road much less traveled for anti-RAS drug discovery. Genes melanoma 2, 275–287 (2011).

  • 113.

    Gonzalez-Garcia, A. et al. RALGDS is required for tumor formation in a mannequin of dermis carcinogenesis. cancer cellphone 7, 219–226 (2005).

  • 114.

    Vigil, D. et al. Aberrant overexpression of the RGL2 RAL small GTPase-selected guanine nucleotide alternate aspect promotes pancreatic cancer boom through RAL-elegant and RAL-unbiased mechanisms. J. Biol. Chem. 285, 34729–34740 (2010).

  • a hundred and fifteen.

    Lim, okay. H. et al. Divergent roles for RALA and RALB in malignant growth of human pancreatic carcinoma cells. Curr. Biol. 16, 2385–2394 (2006).

  • 116.

    Peschard, P. et al. Genetic deletion of RALA and RALB small GTPases reveals redundant features in construction and tumorigenesis. Curr. Biol. 22, 2063–2068 (2012).

  • 117.

    Wu, J. C. et al. Identification of V23RALA-Ser194 as a well-known mediator for Aurora-A-precipitated mobile motility and transformation via small pool expression screening. J. Biol. Chem. 280, 9013–9022 (2005).

  • 118.

    Lim, k. H. et al. Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA. Mol. cellphone. Biol. 30, 508–523 (2010).

  • 119.

    Wang, H. et al. Phosphorylation of RALB is essential for bladder cancer mobilephone augment and metastasis. cancer Res. 70, 8760–8769 (2010).

  • 120.

    Martin, T. D., Mitin, N., Cox, A. D., Yeh, J. J. & Der, C. J. Phosphorylation by means of protein kinase Cα regulates RALB small GTPase protein activation, subcellular localization, and effector utilization. J. Biol. Chem. 287, 14827–14836 (2012).

  • 121.

    Chien, Y. et al. RALB GTPase-mediated activation of the IκB family kinase TBK1 couples inborn immune signaling to tumor mobile survival. phone 127, 157–a hundred and seventy (2006).

  • 122.

    Martin, T. D. et al. RAL and RHEB GTPase activating proteins integrate mTOR and GTPase signaling in getting old, autophagy, and tumor phone invasion. Mol. cell fifty three, 209–220 (2014).

  • 123.

    Malliri, A. et al. Mice deficient within the RAC activator TIAM1 are proof against RAS-caused skin tumours. Nature 417, 867–871 (2002).

  • 124.

    Lambert, J. M. et al. TIAM1 mediates RAS activation of RAC via a PI(three)k-unbiased mechanism. Nature cellphone Biol. four, 621–625 (2002).

  • 125.

    Welch, H. C. et al. P-REX1, a PtdIns(three,four,5)P3- and Gβγ-regulated guanine-nucleotide exchange component for RAC. telephone 108, 809–821 (2002).

  • 126.

    Hodis, E. et al. A panorama of driver mutations in melanoma. mobile a hundred and fifty, 251–263 (2012).

  • 127.

    Krauthammer, M. et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nature Genet. 44, 1006–1014 (2012).

  • 128.

    Kissil, J. L. et al. Requirement for RAC1 in a KRAS brought about lung cancer in the mouse. cancer Res. sixty seven, 8089–8094 (2007).

  • 129.

    Heid, I. et al. Early requirement of RAC1 in a mouse mannequin of pancreatic melanoma. Gastroenterol 141, 719–730.e7 (2011).

  • a hundred thirty.

    Cardama, G. A. et al. Preclinical construction of novel RAC1–GEF signaling inhibitors using a rational design fashion in tremendously aggressive breast cancer cellphone traces. Anticancer agents Med. Chem. 14, 840–851 (2013).

  • 131.

    Gao, Y., Dickerson, J. B., Guo, F., Zheng, J. & Zheng, Y. Rational design and characterization of a RAC GTPase-selected small molecule inhibitor. Proc. Natl Acad. Sci. united states of america 101, 7618–7623 (2004).

  • 132.

    Chow, H. Y. et al. p21-activated kinase 1 is required for efficient tumor formation and progress in a RAS-mediated skin melanoma model. cancer Res. 72, 5966–5975 (2012).

  • 133.

    Fritsch, R. et al. RAS and RHO families of GTPases directly regulate separate phosphoinositide 3-kinase isoforms. telephone 153, 1050–1063 (2013).

  • 134.

    Chan, J. J. & Katan, M. PLCε and the RASSF family in tumour suppression and other features. Adv. Biol. Regul. fifty three, 258–279 (2013).

  • a hundred thirty five.

    Hartman, J. L. 4th, Garvik, B. & Hartwell, L. principles for the buffering of genetic edition. Science 291, 1001–1004 (2001).

  • 136.

    Kaelin, W. G. Jr. The concept of ersatz lethality in the context of anticancer remedy. Nature Rev. cancer 5, 689–698 (2005).

  • 137.

    Hanahan, D. & Weinberg, R. A. The hallmarks of melanoma. cellphone 100, fifty seven–70 (2000).

  • 138.

    Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next era. cell one hundred forty four, 646–674 (2011).

  • 139.

    Luo, J., Solimini, N. L. & Elledge, S. J. principles of melanoma remedy: oncogene and non-oncogene addiction. phone 136, 823–837 (2009).

  • a hundred and forty.

    Yu, B. & Luo, J. in Inhibitors of the RAS Superfamily G-proteins, half B. (eds. Tamanoi, F. & Der, C. J.) 201–215 (educational Press, 2013).

  • 141.

    Cox, A. D. & Der, C. J. The dusky side of RAS: law of apoptosis. Oncogene 22, 8999–9006 (2003).

  • 142.

    Kumar, M. S. et al. The GATA2 transcriptional community is requisite for RAS oncogene-driven non-small phone lung cancer. mobilephone 149 642–655 (2012).

  • 143.

    Luo, J. et al. A genome-extensive RNAi disclose identifies multiple synthetic lethal interactions with the RAS oncogene. cell 137, 835–848 (2009). here is considered one of a number of stories describing significant-scale RNAi monitors aiming to identify ersatz lethal partners of the KRAS oncogene.

  • a hundred and forty four.

    Barbie, D. A. et al. Systematic RNA interference exhibits that oncogenic KRAS-pushed cancers require TBK1. Nature 462, 108–112 (2009).

  • 145.

    Steckel, M. et al. election of ersatz deadly interactions in KRAS oncogene-dependent cancer cells displays novel therapeutic focused on innovations. cellphone Res. 22, 1227–1245 (2012).

  • 146.

    Carretero, J. et al. Integrative genomic and proteomic analyses determine objectives for LKB1-deficient metastatic lung tumors. melanoma telephone 17, 547–559 (2010).

  • 147.

    Kim, H. S. et al. Systematic identification of molecular subtype-selective vulnerabilities in non-small-telephone lung cancer. phone one hundred fifty five, 552–566 (2013).

  • 148.

    Garraway, L. A. & marketers, W. R. Lineage dependency and lineage-survival oncogenes in human cancer. Nature Rev. melanoma 6, 593–602 (2006).

  • 149.

    Kapoor, A. et al. YAP1 activation makes it workable for skip of oncogenic KRAS dependancy in pancreatic cancer. mobile 158, 185–197 (2014). This study, together with reference 150, recognized a novel bypass mechanism that may render KRAS-addicted cancer cells proof against RAS-targeted remedy.

  • 150.

    Shao, D. D. et al. KRAS and YAP1 converge to alter EMT and tumor survival. phone 158, 171–184 (2014).

  • 151.

    Cheung, H. W. et al. Systematic investigation of genetic vulnerabilities throughout melanoma phone traces exhibits lineage-specific dependencies in ovarian melanoma. Proc. Natl Acad. Sci. u . s . a . 108, 12372–12377 (2011).

  • 152.

    Marcotte, R. et al. elementary gene profiles in breast, pancreatic, and ovarian cancer cells. cancer Discov. 2, 172–189 (2012).

  • 153.

    Barretina, J. et al. The cancer telephone Line Encyclopedia allows for predictive modelling of anticancer drug sensitivity. Nature 483, 603–607 (2012).

  • 154.

    Anderson, S. N., Towne, D. L., Burns, D. J. & Warrior, U. A high-throughput smooth agar assay for identification of anticancer compound. J. Biomol. disclose 12, 938–945 (2007).

  • 155.

    Meacham, C. E., Ho, E. E., Dubrovsky, E., Gertler, F. B. & Hemann, M. T. In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma development. Nature Genet. 41, 1133–1137 (2009).

  • 156.

    Zuber, J. et al. An built-in approach to dissecting oncogene dependancy implicates a MYB-coordinated self-renewal software as primary for leukemia renovation. Genes Dev. 25, 1628–1640 (2011).

  • 157.

    Possemato, R. et al. practical genomics demonstrate that the serine synthesis pathway is standard in breast cancer. Nature 476, 346–350 (2011).

  • 158.

    Murugaesu, N. et al. An in vivo purposeful screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor. cancer Discov. 4, 304–317 (2014).

  • 159.

    Schramek, D. et al. Direct in vivo RNAi parade unveils myosin IIa as a tumor suppressor of squamous phone carcinomas. Science 343, 309–313 (2014).

  • a hundred and sixty.

    Zender, L. et al. An oncogenomics-primarily based in vivo RNAi parade identifies tumor suppressors in liver cancer. mobilephone 135, 852–864 (2008).

  • 161.

    Kumar, M. S. et al. The GATA2 transcriptional community is requisite for RAS oncogene-driven non-small cell lung cancer. mobile 149, 642–655 (2012).

  • 162.

    Luo, T. et al. STK33 kinase inhibitor BRD-8899 has no consequence on KRAS-stylish melanoma mobile viability. Proc. Natl Acad. Sci. country 109, 2860–2865 (2012).

  • 163.

    Muvaffak, A. et al. Evaluating TBK1 as a therapeutic target in cancers with activated IRF3. Mol. melanoma Res. 12, 1055–1066 (2014).

  • 164.

    Zhu, Z. et al. Inhibition of KRAS-pushed tumorigenicity by using interruption of an autocrine cytokine circuit. melanoma Discov. 4, 452–465 (2014).

  • a hundred sixty five.

    Corcoran, R. B. et al. synthetic deadly interplay of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant melanoma fashions. melanoma phone 23, 121–128 (2013).

  • 166.

    Ran, F. A. et al. Genome engineering the exercise of the CRISPR-Cas9 equipment. Nature Protoc. 8, 2281–2308 (2013).

  • 167.

    Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84–87 (2014).

  • 168.

    Wang, T., Wei, J. J., Sabatini, D. M. & Lander, E. S. Genetic monitors in human cells the exercise of the CRISPR-Cas9 system. Science 343, 80–84 (2014).

  • 169.

    Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. figuring out the Warburg impact: the metabolic necessities of mobilephone proliferation. Science 324, 1029–1033 (2009).

  • 170.

    DeBerardinis, R. J. & Thompson, C. B. cellular metabolism and ailment: what carry out metabolic outliers school us? cellphone 148, 1132–1144 (2012).

  • 171.

    Lunt, S. Y. & Vander Heiden, M. G. aerobic glycolysis: assembly the metabolic requirements of mobile proliferation. Annu. Rev. mobilephone Dev. Biol. 27, 441–464 (2011).

  • 172.

    Stine, Z. E. & Dang, C. V. Stress consuming and tuning out: cancer cells re-wire metabolism to counter stress. Crit. Rev. Biochem. Mol. Biol. 48, 609–619 (2013).

  • 173.

    Levine, A. J. & Puzio-Kuter, A. M. The manage of the metabolic swap in cancers with the aid of oncogenes and tumor suppressor genes. Science 330, 1340–1344 (2010).

  • 174.

    Racker, E., Resnick, R. J. & Feldman, R. Glycolysis and methylaminoisobutyrate uptake in rat-1 cells transfected with ras or myc oncogenes. Proc. Natl Acad. Sci. us of a 82, 3535–3538 (1985).

  • one hundred seventy five.

    clever, D. R. et al. MYC regulates a transcriptional application that stimulates mitochondrial glutaminolysis and leads to glutamine dependancy. Proc. Natl Acad. Sci. united states a hundred and five, 18782–18787 (2008).

  • 176.

    Son, J. et al. Glutamine helps pancreatic cancer augment through a KRAS-regulated metabolic pathway. Nature 496, one hundred and one–105 (2013). This paper indicates that pancreatic cancers confidence on glutamine, which is utilized with the aid of a KRAS-regulated pathway it really is essential for keeping redox homeostasis.

  • 177.

    White, E. Exploiting the unhealthy eating habits of RAS-pushed cancers. Genes Dev. 27, 2065–2071 (2013).

  • 178.

    Yang, Z. & Klionsky, D. J. Eaten alive: a history of macroautophagy. Nature cell Biol. 12, 814–822 (2010).

  • 179.

    Kimmelman, A. C. The dynamic nature of autophagy in cancer. Genes Dev. 25, 1999–2010 (2011).

  • 180.

    Mah, L. Y. & Ryan, ok. M. Autophagy and melanoma. glacial Spring Harb. Perspect. Biol. 4, a008821 (2012).

  • 181.

    White, E. Deconvoluting the context-dependent position for autophagy in cancer. Nature Rev. melanoma 12, 401–410 (2012).

  • 182.

    Guo, J. Y. et al. Activated RAS requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 25, 460–470 (2011).

  • 183.

    Guo, J. Y. et al. Autophagy suppresses progress of KRAS-caused lung tumors to oncocytomas and continues lipid homeostasis. Genes Dev. 27, 1447–1461 (2013).

  • 184.

    Lock, R. et al. Autophagy enables glycolysis during RAS-mediated oncogenic transformation. Mol. Biol. cellphone 22, one hundred sixty five–178 (2011).

  • 185.

    Yang, S. et al. Pancreatic cancers require autophagy for tumor boom. Genes Dev. 25, 717–729 (2011).

  • 186.

    Rao, S. et al. A twin role for autophagy in a murine model of lung melanoma. Nature Commun. 5, 3056 (2014).

  • 187.

    Rosenfeldt, M. T. et al. p53 popularity determines the function of autophagy in pancreatic tumour building. Nature 504, 296–300 (2013).

  • 188.

    Yang, A. et al. Autophagy is vital for pancreatic tumor growth and progression in tumors with p53 transformations. melanoma Discov. four, 905–913 (2014).

  • 189.

    Amaravadi, R. okay. et al. concepts and present innovations for targeting autophagy for melanoma treatment. Clin. melanoma Res. 17, 654–666 (2011).

  • one hundred ninety.

    Mancias, J. D. & Kimmelman, A. C. targeting autophagy addiction in cancer. Oncotarget 2, 1302–1306 (2011).

  • 191.

    Prior, I. A., Lewis, P. D. & Mattos, C. A finished survey of RAS mutations in cancer. cancer Res. seventy two, 2457–2467 (2012).

  • 192.

    Yang, Z. & Klionsky, D. J. Mammalian autophagy: core molecular paraphernalia and signaling rules. Curr. Opin. cellphone Biol. 22, 124–131 (2010).

  • 193.

    Bar-Sagi, D. & Feramisco, J. R. Induction of membrane ruffling and fluid-section pinocytosis in quiescent fibroblasts by ras proteins. Science 233, 1061–1068 (1986).

  • 194.

    Lim, J. P. & Gleeson, P. A. Macropinocytosis: an endocytic pathway for internalising massive gulps. Immunol. cellphone Biol. 89, 836–843 (2011).

  • 195.

    Commisso, C. et al. Macropinocytosis of protein is an amino acid give route in RAS-changed cells. Nature 497, 633–637 (2013).

  • 196.

    Kamphorst, J. J. et al. Hypoxic and RAS-changed cells assist growth by scavenging unsaturated fatty acids from lysophospholipids. Proc. Natl Acad. Sci. usa 110, 8882–8887 (2013).

  • 197.

    Yun, J. et al. Glucose deprivation contributes to the progress of KRAS pathway mutations in tumor cells. Science 325, 1555–1559 (2009).

  • 198.

    McCleland, M. L. et al. Lactate dehydrogenase B is required for the growth of KRAS-elegant lung adenocarcinomas. Clin. cancer Res. 19, 773–784 (2013).

  • 199.

    Patra, ok. C. et al. Hexokinase 2 is required for tumor initiation and upkeep and its systemic deletion is therapeutic in mouse models of melanoma. cancer mobilephone 24, 213–228 (2013).

  • 200.

    Gaglio, D. et al. Oncogenic KRAS decouples glucose and glutamine metabolism to pilot melanoma telephone growth. Mol. Syst. Biol. 7, 523 (2011).

  • 201.

    Weinberg, F. et al. Mitochondrial metabolism and ROS generation are standard for KRAS-mediated tumorigenicity. Proc. Natl Acad. Sci. u . s . 107, 8788–8793 (2010).

  • 202.

    Shukla, k. et al. Design, synthesis, and pharmacological assessment of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors. J. Med. Chem. fifty five, 10551–10563 (2012).

  • 203.

    Thornburg, J. M. et al. targeting aspartate aminotransferase in breast melanoma. Breast melanoma Res. 10, R84 (2008).

  • 204.

    Nguyen, T., Nioi, P. & Pickett, C. B. The NRF2-antioxidant response component signaling pathway and its activation via oxidative stress. J. Biol. Chem. 284, 13291–13295 (2009).

  • 205.

    DeNicola, G. M. et al. Oncogene-induced Nrf2 transcription promotes ROS cleansing and tumorigenesis. Nature 475, 106–109 (2011).

  • 206.

    To, M. D. et al. Kras regulatory facets and exon 4A examine mutation specificity in lung cancer. Nature Genet. 40, 1240–1244 (2008).

  • 207.

    Lampson, B. L. et al. rare codons alter KRAS oncogenesis. Curr. Biol. 23, 70–seventy five (2013).

  • 208.

    Abubaker, J. et al. Prognostic importance of modifications in KRAS isoforms KRAS4A/4B and KRAS mutations in colorectal carcinoma. J. Pathol. 219, 435–445 (2009).

  • 209.

    De Roock, W. et al. affiliation of KRAS p.G13D mutation with influence in sufferers with chemotherapy-refractory metastatic colorectal melanoma handled with cetuximab. JAMA 304, 1812–1820 (2010).

  • 210.

    Tejpar, S. et al. affiliation of KRAS G13D tumor mutations with result in patients with metastatic colorectal cancer handled with first-line chemotherapy with or without cetuximab. J. Clin. Oncol. 30, 3570–3577 (2012).

  • 211.

    Ihle, N. T. et al. impact of KRAS oncogene substitutions on protein conduct: implications for signaling and scientific effect. J. Natl cancer Inst. 104, 228–239 (2012).

  • 212.

    Zhang, Z. et al. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nature Genet. 29, 25–33 (2001).

  • 213.

    Bremner, R. & Balmain, A. Genetic adjustments in skin tumor development: correlation between presence of a mutant ras gene and lack of heterozygosity on mouse chromosome 7. mobile sixty one, 407–417 (1990).

  • 214.

    Li, H. et al. augment inhibitory impact of untamed-classification KRAS2 gene on a colonic adenocarcinoma phone line. World J. Gastroenterol. 13, 934–938 (2007).

  • 215.

    Qiu, W. et al. Disruption of p16 and activation of KRAS in pancreas enhance ductal adenocarcinoma formation and metastasis in vivo. Oncotarget 2, 862–873 (2011).

  • 216.

    Lin, W. C. et al. HRAS types dimers on membrane surfaces via a protein–protein interface. Proc. Natl Acad. Sci. us of a 111, 2996–3001 (2014).

  • 217.

    Xu, J. et al. dominant function of oncogene dosage and absence of tumor suppressor recreation in NRAS-driven hematopoietic transformation. cancer Discov. 3, 993–1001 (2013).

  • 218.

    Grabocka, E. et al. Wild-category H- and N-RAS promote mutant KRAS-driven tumorigenesis by modulating the DNA harm response. melanoma telephone 25, 243–256 (2014).

  • 219.

    younger, A., Lou, D. & McCormick, F. Oncogenic and wild-type RAS play divergent roles within the law of mitogen-activated protein kinase signaling. melanoma Discov. three, 112–123 (2013).

  • 220.

    Vonderheide, R. H. & Nathanson, ok. L. Immunotherapy at giant: the highway to personalized cancer vaccines. Nature Med. 19, 1098–1100 (2013).

  • 221.

    Bayne, L. J. et al. Tumor-derived granulocyte-macrophage colony-stimulating aspect regulates myeloid inflammation and T cell immunity in pancreatic melanoma. cancer telephone 21, 822–835 (2012).

  • 222.

    Pylayeva-Gupta, Y., Lee, ok. E., Hajdu, C. H., Miller, G. & Bar-Sagi, D. Oncogenic KRAS-brought about GM-CSF creation promotes the construction of pancreatic neoplasia. cancer phone 21, 836–847 (2012). This examine, along with reference 221, defined captious mechanisms of crosstalk between the immune system and tumour development.

  • 223.

    Pecot, C. V., Calin, G. A., Coleman, R. L., Lopez-Berestein, G. & Sood, A. okay. RNA interference within the hospital: challenges and future instructions. Nature Rev. cancer 11, 59–67 (2011).

  • 224.

    Thompson, H. J. et al. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. melanoma Res. 57, 267–271 (1997).

  • 225.

    Sarthy, A. V. et al. Survivin depletion preferentially reduces the survival of activated KRAS-modified cells. Mol. melanoma Ther. 6, 269–276 (2007).

  • 226.

    Morgan-Lappe, S. E. et al. Identification of RAS-linked nuclear protein, focused on protein for Xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising melanoma goals from an RNAi-based mostly reveal. cancer Res. 67, 4390–4398 (2007).

  • 227.

    Scholl, C. et al. ersatz lethal interaction between oncogenic KRAS dependency and STK33 suppression in human melanoma cells. phone 137, 821–834 (2009).

  • 228.

    Vicent, S. et al. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. J. Clin. form investments. a hundred and twenty, 3940–3952 (2010).

  • 229.

    Wang, Y. et al. well-known role for transcriptional repressor SNAIL2 in transformation via oncogenic RAS in colorectal carcinoma cells. Oncogene 29, 4658–4670 (2010).

  • 230.

    Singh, A. et al. TAK1 inhibition promotes apoptosis in KRAS-based colon cancers. mobile 148, 639–650 (2012).

  • 231.

    Cullis, J. et al. The RHOGEF GEF-H1 is required for oncogenic RAS signaling by course of KSR1. melanoma mobilephone 25, 181–195 (2014).

  • Direct Download of over 5500 Certification Exams

    3COM [8 Certification Exam(s) ]
    AccessData [1 Certification Exam(s) ]
    ACFE [1 Certification Exam(s) ]
    ACI [3 Certification Exam(s) ]
    Acme-Packet [1 Certification Exam(s) ]
    ACSM [4 Certification Exam(s) ]
    ACT [1 Certification Exam(s) ]
    Admission-Tests [12 Certification Exam(s) ]
    ADOBE [92 Certification Exam(s) ]
    AFP [1 Certification Exam(s) ]
    AICPA [2 Certification Exam(s) ]
    AIIM [1 Certification Exam(s) ]
    Alcatel-Lucent [13 Certification Exam(s) ]
    Alfresco [1 Certification Exam(s) ]
    Altiris [3 Certification Exam(s) ]
    Amazon [2 Certification Exam(s) ]
    American-College [2 Certification Exam(s) ]
    Android [4 Certification Exam(s) ]
    APA [1 Certification Exam(s) ]
    APC [2 Certification Exam(s) ]
    APICS [2 Certification Exam(s) ]
    Apple [69 Certification Exam(s) ]
    AppSense [1 Certification Exam(s) ]
    APTUSC [1 Certification Exam(s) ]
    Arizona-Education [1 Certification Exam(s) ]
    ARM [1 Certification Exam(s) ]
    Aruba [6 Certification Exam(s) ]
    ASIS [2 Certification Exam(s) ]
    ASQ [3 Certification Exam(s) ]
    ASTQB [8 Certification Exam(s) ]
    Autodesk [2 Certification Exam(s) ]
    Avaya [95 Certification Exam(s) ]
    Axis [1 Certification Exam(s) ]
    Banking [1 Certification Exam(s) ]
    BEA [5 Certification Exam(s) ]
    BICSI [2 Certification Exam(s) ]
    BlackBerry [17 Certification Exam(s) ]
    BlueCoat [2 Certification Exam(s) ]
    Brocade [4 Certification Exam(s) ]
    Business-Objects [11 Certification Exam(s) ]
    Business-Tests [4 Certification Exam(s) ]
    CA-Technologies [21 Certification Exam(s) ]
    Certification-Board [10 Certification Exam(s) ]
    Certiport [3 Certification Exam(s) ]
    CheckPoint [40 Certification Exam(s) ]
    CIPS [4 Certification Exam(s) ]
    Cisco [315 Certification Exam(s) ]
    Citrix [46 Certification Exam(s) ]
    CIW [17 Certification Exam(s) ]
    Cloudera [10 Certification Exam(s) ]
    Cognos [19 Certification Exam(s) ]
    College-Board [2 Certification Exam(s) ]
    CompTIA [74 Certification Exam(s) ]
    ComputerAssociates [6 Certification Exam(s) ]
    CPP-Institute [1 Certification Exam(s) ]
    CSP [1 Certification Exam(s) ]
    CWNA [1 Certification Exam(s) ]
    CWNP [13 Certification Exam(s) ]
    Dassault [2 Certification Exam(s) ]
    DELL [9 Certification Exam(s) ]
    DMI [1 Certification Exam(s) ]
    ECCouncil [21 Certification Exam(s) ]
    ECDL [1 Certification Exam(s) ]
    EMC [127 Certification Exam(s) ]
    Enterasys [13 Certification Exam(s) ]
    Ericsson [5 Certification Exam(s) ]
    Esri [2 Certification Exam(s) ]
    ExamExpress [15 Certification Exam(s) ]
    Exin [40 Certification Exam(s) ]
    ExtremeNetworks [3 Certification Exam(s) ]
    F5-Networks [20 Certification Exam(s) ]
    FCTC [2 Certification Exam(s) ]
    Filemaker [9 Certification Exam(s) ]
    Financial [36 Certification Exam(s) ]
    Fortinet [12 Certification Exam(s) ]
    Foundry [6 Certification Exam(s) ]
    Fujitsu [2 Certification Exam(s) ]
    GAQM [8 Certification Exam(s) ]
    Genesys [4 Certification Exam(s) ]
    GIAC [15 Certification Exam(s) ]
    Google [4 Certification Exam(s) ]
    GuidanceSoftware [2 Certification Exam(s) ]
    H3C [1 Certification Exam(s) ]
    HDI [9 Certification Exam(s) ]
    Healthcare [3 Certification Exam(s) ]
    HIPAA [2 Certification Exam(s) ]
    Hitachi [28 Certification Exam(s) ]
    Hortonworks [4 Certification Exam(s) ]
    Hospitality [2 Certification Exam(s) ]
    HP [744 Certification Exam(s) ]
    HR [2 Certification Exam(s) ]
    HRCI [1 Certification Exam(s) ]
    Huawei [21 Certification Exam(s) ]
    Hyperion [10 Certification Exam(s) ]
    IAAP [1 Certification Exam(s) ]
    IBM [1520 Certification Exam(s) ]
    IBQH [1 Certification Exam(s) ]
    ICAI [1 Certification Exam(s) ]
    ICDL [6 Certification Exam(s) ]
    IEEE [1 Certification Exam(s) ]
    IELTS [1 Certification Exam(s) ]
    IFPUG [1 Certification Exam(s) ]
    IIA [3 Certification Exam(s) ]
    IIBA [2 Certification Exam(s) ]
    IISFA [1 Certification Exam(s) ]
    Intel [2 Certification Exam(s) ]
    IQN [1 Certification Exam(s) ]
    IRS [1 Certification Exam(s) ]
    ISA [1 Certification Exam(s) ]
    ISACA [4 Certification Exam(s) ]
    ISC2 [6 Certification Exam(s) ]
    ISEB [24 Certification Exam(s) ]
    Isilon [4 Certification Exam(s) ]
    ISM [6 Certification Exam(s) ]
    iSQI [7 Certification Exam(s) ]
    ITEC [1 Certification Exam(s) ]
    Juniper [63 Certification Exam(s) ]
    Legato [5 Certification Exam(s) ]
    Liferay [1 Certification Exam(s) ]
    Lotus [66 Certification Exam(s) ]
    LPI [23 Certification Exam(s) ]
    LSI [3 Certification Exam(s) ]
    Magento [3 Certification Exam(s) ]
    Maintenance [2 Certification Exam(s) ]
    McAfee [8 Certification Exam(s) ]
    McData [3 Certification Exam(s) ]
    Medical [25 Certification Exam(s) ]
    Microsoft [362 Certification Exam(s) ]
    Mile2 [2 Certification Exam(s) ]
    Military [1 Certification Exam(s) ]
    Misc [1 Certification Exam(s) ]
    Motorola [7 Certification Exam(s) ]
    mySQL [4 Certification Exam(s) ]
    NCLEX [2 Certification Exam(s) ]
    Network-General [12 Certification Exam(s) ]
    NetworkAppliance [36 Certification Exam(s) ]
    NI [1 Certification Exam(s) ]
    NIELIT [1 Certification Exam(s) ]
    Nokia [6 Certification Exam(s) ]
    Nortel [130 Certification Exam(s) ]
    Novell [37 Certification Exam(s) ]
    OMG [10 Certification Exam(s) ]
    Oracle [262 Certification Exam(s) ]
    P&C [1 Certification Exam(s) ]
    Palo-Alto [4 Certification Exam(s) ]
    PARCC [1 Certification Exam(s) ]
    PayPal [1 Certification Exam(s) ]
    Pegasystems [11 Certification Exam(s) ]
    PEOPLECERT [4 Certification Exam(s) ]
    PMI [15 Certification Exam(s) ]
    Polycom [2 Certification Exam(s) ]
    PostgreSQL-CE [1 Certification Exam(s) ]
    Prince2 [6 Certification Exam(s) ]
    PRMIA [1 Certification Exam(s) ]
    PsychCorp [1 Certification Exam(s) ]
    PTCB [2 Certification Exam(s) ]
    QAI [1 Certification Exam(s) ]
    QlikView [1 Certification Exam(s) ]
    Quality-Assurance [7 Certification Exam(s) ]
    RACC [1 Certification Exam(s) ]
    Real-Estate [1 Certification Exam(s) ]
    RedHat [8 Certification Exam(s) ]
    RES [5 Certification Exam(s) ]
    Riverbed [8 Certification Exam(s) ]
    RSA [15 Certification Exam(s) ]
    Sair [8 Certification Exam(s) ]
    Salesforce [5 Certification Exam(s) ]
    SANS [1 Certification Exam(s) ]
    SAP [98 Certification Exam(s) ]
    SASInstitute [15 Certification Exam(s) ]
    SAT [1 Certification Exam(s) ]
    SCO [10 Certification Exam(s) ]
    SCP [6 Certification Exam(s) ]
    SDI [3 Certification Exam(s) ]
    See-Beyond [1 Certification Exam(s) ]
    Siemens [1 Certification Exam(s) ]
    Snia [7 Certification Exam(s) ]
    SOA [15 Certification Exam(s) ]
    Social-Work-Board [1 Certification Exam(s) ]
    SpringSource [1 Certification Exam(s) ]
    SUN [63 Certification Exam(s) ]
    SUSE [1 Certification Exam(s) ]
    Sybase [17 Certification Exam(s) ]
    Symantec [133 Certification Exam(s) ]
    Teacher-Certification [4 Certification Exam(s) ]
    The-Open-Group [8 Certification Exam(s) ]
    TIA [3 Certification Exam(s) ]
    Tibco [18 Certification Exam(s) ]
    Trend [1 Certification Exam(s) ]
    TruSecure [1 Certification Exam(s) ]
    USMLE [1 Certification Exam(s) ]
    VCE [6 Certification Exam(s) ]
    Veeam [2 Certification Exam(s) ]
    Veritas [32 Certification Exam(s) ]
    Vmware [57 Certification Exam(s) ]
    Wonderlic [1 Certification Exam(s) ]
    Worldatwork [2 Certification Exam(s) ]
    XML-Master [3 Certification Exam(s) ]
    Zend [6 Certification Exam(s) ]

    References :

    Dropmark :
    Wordpress :
    Issu :
    Dropmark-Text :
    Blogspot :
    RSS Feed : : : :

    Back to Main Page | | |